Detalhe da pesquisa
1.
Predictors of treatment outcome in patients with paediatric onset multiple sclerosis.
Mult Scler
; 26(8): 964-975, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31081451
2.
The Multiple Sclerosis Care Unit.
Mult Scler
; 25(5): 627-636, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30351211
3.
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.
Mult Scler
; 25(11): 1444-1451, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30113249
4.
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
Mult Scler
; 25(6): 819-827, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716436
5.
Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis.
Mult Scler
; 25(9): 1298-1305, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30070595
6.
Evolving concepts in the treatment of relapsing multiple sclerosis.
Lancet
; 389(10076): 1347-1356, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27889192
7.
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
Mult Scler
; 24(12): 1594-1604, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870107
8.
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.
Mult Scler
; 24(5): 590-603, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28671487
9.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Mult Scler
; 23(2): 234-241, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055806
10.
Employment, disability pension and income for children with parental multiple sclerosis.
Mult Scler
; 23(8): 1148-1156, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27682230
11.
Defining active progressive multiple sclerosis.
Mult Scler
; 23(13): 1727-1735, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28831853
12.
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Mult Scler
; 23(5): 675-685, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27481206
13.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Mult Scler
; 22(11): 1386-1396, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27207462
14.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Mult Scler
; 22(7): 944-54, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26447066
15.
Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis.
Mult Scler
; 21(11): 1414-22, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533295
16.
Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment.
Mult Scler Relat Disord
; 88: 105701, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38889559
17.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
N Engl J Med
; 362(5): 416-26, 2010 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20089960
18.
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.
CNS Drugs
; 36(3): 283-300, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233753
19.
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO.
Mult Scler
; 22(10): 1260-3, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27444559
20.
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
Mult Scler
; 22(9): 1112-3, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27364323